The near-term trigger for the stock is its plan to acquire Amplitude Surgical. Amplitude had a 5 per cent year-on-year (Y-o-Y ...

Zydus Lifesciences has announced that the US Food and Drug Administration (USFDA) conducted a surveillance inspection at the company's Active Pharmaceutical Ingredient (API) Unit 1, located in ...

Zydus Lifesciences is working to advance its position in the global pharmaceutical sector by increasing its focus on medical ...

Zydus Lifesciences Ltd on Wednesday (March 12) the company's venture capital arm Zynext Ventures USA LLC has announced an ...

India still relies largely on imported devices and implants, when it comes to MedTech. This offers us a great opportunity to ...

Ahmedabad: Zydus Lifesciences has announced that the US Food and Drug Administration (USFDA) has concluded a surveillance ...

Zydus is set to acquire France-based orthopedic device maker Amplitude Surgical for up to €300 million (around $326 million).

Medical Technology includes medical devices and related scientific infrastructure that directly contribute to the development ...

Zydus Lifesciences receives USFDA approval for Methenamine Hippurate Tablets, strengthening position in US market.

India's Zydus Lifesciences is set to acquire an 85.6% stake in France's Amplitude Surgical for nearly $280 million to expand ...

Amplitude Surgical is a leading French player in the global market for surgical technologies for lower limb orthopaedics and ...

Zydus Lifesciences will acquire a majority stake in Amplitude Surgical, a European MedTech leader in lower-limb orthopaedic ...